LPCN übertreffen die 27 der letzten 40Schätzungen.
68%
Nächster Bericht
Datum des nächsten Berichts
11. März 2026
Estimate forQ4 25(Revenue/ EPS)
$118.32K
/
-$0.62
Implizierte Änderung vonQ3 25(Revenue/ EPS)
+2.89%
/
+5.08%
Implizierte Änderung vonQ4 24(Revenue/ EPS)
-96.61%
/
-133.33%
Lipocine Inc. earnings per share and revenue
On 06. Nov. 2025, LPCN reported earnings of -0.59 USD per share (EPS) for Q3 25, missing the estimate of -0.55 USD, resulting in a -7.12% surprise. Revenue reached 115.00 tausend, compared to an expected 242.76 tausend, with a -52.63% difference. The market reacted with a +3.13% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 4 analysts forecast an EPS of -0.62 USD, with revenue projected to reach 118.32 tausend USD, implying an increase of 5.08% EPS, and increase of 2.89% in Revenue from the last quarter.
FAQ
What were Lipocine Inc.'s earnings and revenue for the latest quarter Q3 2025?
For Q3 2025, Lipocine Inc. reported EPS of -$0.59, missing estimates by -7.12%, and revenue of $115.00K, -52.63% below expectations.
How did the market react to Lipocine Inc.'s Q3 2025 earnings?
The stock price moved up 3.13%, changed from $2.56 before the earnings release to $2.64 the day after.
When is Lipocine Inc. expected to report next?
The next earning report is scheduled for 11. März 2026.
What are the forecasts for Lipocine Inc.'s next earnings report?
Based on 4
analysts, Lipocine Inc. is expected to report EPS of -$0.62 and revenue of $118.32K for Q4 2025.